These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35404898)

  • 1. Survival Impact of Perioperative Red Blood Cell Transfusion During Pancreatectomy in Patients With Pancreatic Ductal Adenocarcinoma: A Propensity Score Matching Analysis.
    Kitano Y; Yamashita YI; Matsumoto T; Kinoshita S; Itoyama R; Kaida T; Hayashi H; Imai K; Chikamoto A; Baba H
    Pancreas; 2022 Feb; 51(2):200-204. PubMed ID: 35404898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy.
    Newhook TE; Prakash LR; Soliz J; Hancher-Hodges S; Speer BB; Wilks JA; Bruno ML; Dewhurst WL; Arvide EM; Maxwell JE; Ikoma N; Kim MP; Lee JE; Katz MHG; Tzeng CD
    J Surg Oncol; 2021 Dec; 124(8):1381-1389. PubMed ID: 34398988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
    Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
    J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective study.
    Suto H; Matsukawa H; Fuke T; Nagao M; Ando Y; Oshima M; Yamana H; Kamada H; Kobara H; Okuyama H; Kumamoto K; Okano K
    Pancreatology; 2024 May; 24(3):431-436. PubMed ID: 38383175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive (subtotal) distal pancreatectomy for pancreatic ductal adenocarcinoma: a propensity score matched cohort study of short- and long-term outcomes compared with those of conventional distal pancreatectomy.
    Watanabe Y; Nakata K; Mori Y; Ideno N; Ikenaga N; Ohtsuka T; Nakamura M
    Langenbecks Arch Surg; 2022 Jun; 407(4):1479-1488. PubMed ID: 35146547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.
    Chen K; Pan Y; Huang CJ; Chen QL; Zhang RC; Zhang MZ; Wang GY; Wang XF; Mou YP; Yan JF
    BMC Cancer; 2021 Apr; 21(1):382. PubMed ID: 33836678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative Blood Transfusion and the Prognosis of Pancreatic Cancer Surgery: Systematic Review and Meta-analysis.
    Mavros MN; Xu L; Maqsood H; Gani F; Ejaz A; Spolverato G; Al-Refaie WB; Frank SM; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4382-91. PubMed ID: 26293837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and mid-term outcomes of robotic versus laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma: A retrospective propensity score-matched study.
    Qu L; Zhiming Z; Xianglong T; Yuanxing G; Yong X; Rong L; Yee LW
    Int J Surg; 2018 Jul; 55():81-86. PubMed ID: 29802919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization.
    Snyder RA; Prakash LR; Nogueras-Gonzalez GM; Kim MP; Aloia TA; Vauthey JN; Lee JE; Fleming JB; Katz MHG; Tzeng CD
    HPB (Oxford); 2019 Jul; 21(7):841-848. PubMed ID: 30501986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative blood transfusion has no effect on overall survival after esophageal resection for esophageal squamous cell carcinoma: A retrospective cohort study.
    Liu J; Chen S; Chen Y; Wang N; Ye X
    Int J Surg; 2018 Jul; 55():24-30. PubMed ID: 29578096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma.
    Abe T; Amano H; Hanada K; Minami T; Yonehara S; Hattori M; Kobayashi T; Fukuda T; Nakahara M; Ohdan H; Noriyuki T
    Anticancer Res; 2017 Oct; 37(10):5863-5870. PubMed ID: 28982913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhou PY; Tang Z; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Ding ZB; Peng YF; Qiu SJ; Dai Z; Zhou J; Fan J; Shi YH
    BMC Cancer; 2017 Nov; 17(1):762. PubMed ID: 29137600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection:
    Liu ZP; Cheng ZJ; Dai HS; Zhong SY; Zhao DC; Gong Y; Zuo JH; Che XY; Chen WY; Wang ZR; Yu T; Cheng JJ; Liu XC; Bai J; Jiang Y; Zhang YQ; Lau WY; Deng SQ; Chen ZY
    Front Oncol; 2022; 12():1059581. PubMed ID: 36387093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) undergoing robotic (RPD) or open pancreaticoduodenectomies (OPD): a propensity score-weighted survival analysis.
    Mejia A; Shah J; Vivian E; Beard R; Acharya P; Gutierrez JCB
    J Robot Surg; 2023 Jun; 17(3):1085-1096. PubMed ID: 36581740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse oncologic effects of intraoperative transfusion during pancreatectomy for left-sided pancreatic cancer: the need for strict transfusion policy.
    Hwang HK; Jung MJ; Lee SH; Kang CM; Lee WJ
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):497-507. PubMed ID: 27295957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a single-center propensity score matching study.
    Chen K; Tong Q; Yan JF; Huang CJ; Pan Y; Zhang RC; Chen QL; Zheng XY; Cai XY; Wang Y; Wang XF
    Updates Surg; 2020 Jun; 72(2):387-397. PubMed ID: 32266660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic distal pancreatectomy reduces pancreatic fistula in patients without visceral obesity as compared to open distal pancreatectomy: A propensity score matching retrospective cohort study.
    Chen H; Shen Z; Ying X; Weng Y; Jiang Y; Chen H; Xu Z; Deng X; Xie J; Shen B
    Int J Surg; 2021 Jun; 90():105960. PubMed ID: 33989824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
    Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
    BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological outcomes of robotic pancreatectomy in patients with pancreatic cancer who receive adjuvant chemotherapy: A propensity score-matched retrospective cohort study.
    Weng Y; Shen Z; Gemenetzis G; Jin J; Chen H; Deng X; Peng C; Shen B
    Int J Surg; 2022 Aug; 104():106801. PubMed ID: 35934284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma.
    Abu-Ghanem Y; Zilberman DE; Dotan Z; Kaver I; Ramon J
    Urol Oncol; 2018 Jan; 36(1):12.e15-12.e20. PubMed ID: 28993059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.